Abbott to sell Cholestech's GDX system globally:
This article was originally published in Clinica
Executive Summary
Abbott is to distribute globally Cholestech's GDX system for the determination of glycated haemoglobin, an indicator of long-term glycaemic control. Abbott will also offer the Cholestech LDX system with the two products representing "a full complement of products for immediate risk assessment and therapeutic monitoring of heart disease and diabetes", according the Timothy Still, Hayward, California-based Cholestech's vice-president of sales and marketing.